2023. In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors. Journal of Pharmaceutical Negative Results. (Feb. 2023), 2793–2803. DOI:https://doi.org/10.47750/pnr.2023.14.S02.329.